Cancer Research
-
Pittsburgh Team Finds TPP1 Mutation Helps Melanoma Cells Keep Telomeres Long
PITTSBURGH — Scientists at the University of Pittsburgh School of Medicine have identified a crucial missing piece in the long-standing mystery of…
-
Nutraceutical formula shows potential in cancer treatment study
ISLAMABAD, July 1 — A new study has turned to an unexpected source in the fight against cancer: a nutraceutical formula called…
-
Global Oncology Precision Medicine Market Set for Robust Expansion Through 2031
GLOBAL — July 1, 2026 — The global market for oncology precision medicine is opening up fresh opportunities in diagnostics and therapeutics,…
-
Study: Quitting Smoking for Vaping Raises Lung Cancer Risk 56%
SEOUL — A sweeping new study out of South Korea is casting serious doubt on the idea that switching to e-cigarettes is…
-
Study: Ex-Smokers Who Vape Daily Face 56% Higher Lung Cancer Risk
SEOUL — The numbers are brutal. A 56% higher lung cancer risk for former smokers who swap cigarettes for daily vaping. Not…
-
New Analyses Link Mogamulizumab to Longer Survival in Two Rare Skin Lymphomas
PRINCETON, N.J., June 30 — New analyses are helping doctors better understand the long-term survival picture for patients with two rare forms…
-
QIMR Berghofer study: 70% of Queenslanders used skin cancer services in eight years
For decades, Queensland has been the place where the sun doesn’t just shine — it attacks. The state holds the world’s highest…
-
Spanish Researcher Builds CAR-T Cells Against Rare Childhood Rhabdoid Tumours
A single gene gone wrong. That is the core problem with rhabdoid tumours. And it is the core clue that a Spanish…
-
Zelluna Secures NOK 16 Million Grant for TCR-NK Research
OSLO, June 30 — Zelluna ASA, a company listed on the Oslo Stock Exchange under the ticker ZLNA, has been awarded a…
-
Young cancer survivor Kayla Esson starts Aberdeen Race for Life a year after remission
She went from patient to starter. Kayla Esson, 22, stood at the front of 1,100 runners in Aberdeen on Sunday and blew…
-
Multilevel training model to speed child cancer diagnosis in Ethiopia
ADDIS ABABA — A new training and mentorship model is showing early promise in accelerating the diagnosis of childhood cancer in Northwest…
-
Tiny Antarctic creature may hold key to melanoma treatment
TAMPA, June 29 — The bottom line: a toxin from a tiny sea creature collected off Antarctica has already killed melanoma cells…
-
Cancer signs thousands overlook – ‘won’t contact GP for
LONDON, June 29 — A troubling pattern is emerging across the UK, one that families here and across Asia might recognise all…
-
USF researchers find Antarctic sea squirt compound kills melanoma in mice
TAMPA — Six weeks in Antarctic waters. Dives to 130 feet. Half-hour bottom times. And one compound that killed melanoma in mice…
-
Antarctic sea creature toxin shows melanoma-killing potential in mouse study
A toxin harvested from a tiny sea creature collected off Antarctica has killed melanoma in mice without harming the mice. That fact…
-
Stomach Cancer Surge in Under-50s: Experts Reveal Key Risk Factors
GREENVILLE, S.C., June 28 — Carly Douglas was 34 years old, a mother of three, and an influencer with 140,000 Instagram followers.…
-
Cleveland study finds vitamin B12 compound may cross blood-brain barrier to treat glioblastoma
CLEVELAND — Fifteen months. That is the average survival time for a patient diagnosed with glioblastoma. Surgery, radiation, chemotherapy — standard care…
-
Study Finds Cancers Hiding from T Cells May Be More Vulnerable to Immune Attack
For years, the logic seemed airtight. Cancer cells that stripped away a key molecular flag — MHC class I — were considered…
-
Ella Toone becomes Prostate Cancer UK ambassador after father’s death at 59
Every 45 minutes, a man in the UK dies from prostate cancer. That statistic, from Prostate Cancer UK, is the cold arithmetic…
-
Bowel cancer survivor Adele Roberts details stoma prolapse after fundraiser
Bowel cancer survivor’s stoma struggle laid bare after charity challenge LONDON — Adele Roberts spent an entire night holding her own intestine…
-
Lioness Ella Toone becomes Prostate Cancer UK ambassador after father’s death
One man dies from prostate cancer every 45 minutes in the UK. That statistic, from Prostate Cancer UK, is the cold arithmetic…
-
Lymphoma Research Foundation Awards 24 New Research Grants
NEW YORK, June 17 — The Lymphoma Research Foundation, the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and…
-
Montreal researchers discover SLAMF6 molecule directly shuts down immune cell defenses
MONTREAL — The molecule that shuts down the body’s cancer defenses does not need a middleman. It acts on its own. That…
-
Montreal Researchers Find SLAMF6, an Internal T Cell Brake That Works Without Tumor Input
MONTREAL — The immune system has a self-destruct switch. Cancer cells have learned to flip it. And for years, doctors have been…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
New Studies Show Immunotherapy Gaining Ground in Lung, Prostate and Childhood Cancers
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Why Broad RAS-Targeting Drugs Mark a Turning Point in Treating Pancreatic Cancer
-
How At-Home Igalmi Differs From Traditional Treatments for Schizophrenia and Bipolar Agitation
-
Boron Neutron Capture Therapy Faces US Coverage Hurdles Over Cost and Data Gaps
-
FDA Proposes Slashing Companion Diagnostic Fees From $636,732 to $28,653
-
Biocon’s Pebrilzo FDA Approval Cements Its Role in Affordable Cancer Care
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
























